|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs显示文摘 | Bajorin DF Tong W | 1999 | Clin Cancer Res1999，5，9： | 1 |
| 2 | CD147,EMMPRIN and CD44are potential therapeutic targets for metastatic prostate cancer显示文摘 | Hao JL Cozzi PJ Khatri A | 2010 | Curr Cancer Drug Targets2010，10，3： | 1 |
| 3 | The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression显示文摘 | Madigan MC Kingsley EA Cozzi PJ | 2008 | Cancer Immunol Immunother2008，57，9： | 1 |
| 4 | Targeting uPA/uPAR in prostate cancer显示文摘 | Li Y Cozzi PJ | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 5 | Intravesical oncolytic viral therapy using attenuated replication-competent,herpes simplex viruses G207 is effective in the treatment of bladder cancer in an orthotopic syngeneic model显示文摘 | Cozzi PJ Malhotra S Mcauliffe P | 2001 | FASEB J2001，15，： | 1 |
| 6 | TargetinguPA/uPAR in prostate cancer显示文摘 | Li Y Cozzi PJ | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 7 | MUC1, MUC2, MUC3, MUCA, MUC5AC and MUC6 expression in the progression of prostate cancer显示文摘 | Cozzi PJ Wang J Delprado W | 2005 | Clin Exp Metastasis2005，22，7： | 1 |
| 8 | Targeting uPA/uPAR in prostate cancer显示文摘 | Li Y Cozzi PJ | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 9 | Two cases of spontaneous liver rupture and literature review显示文摘 | Morris DL | 1996 | HPB Surg1996，9，4： | 1 |
| 10 | Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs显示文摘 | COZZI PJ BAJORIN DF TONG W | 1999 | Clin CancerRes1999，5，9： | 1 |
| 11 | MUCI, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer显示文摘 | Cozzi PJ Wang J Delprado W | 2005 | Clin Exp Metastasis2005，22，7： | 1 |
| 12 | MUC1, MUC2, MUC3, MUC4, MUC5 and MUC6 expression in the progression of prostate cancer 显示文摘 | Cozzi PJ Wang J Delprado W | 2005 | J Clin Exp Metastasis2005，22，7： | 1 |
| 13 | Targeting uPA/uPAR in prostate cancer显示文摘 | Li Y Cozzi PJ | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 14 | MUC1,MUC2,MUC4,MUC5AC and MUC6 expression in the progression of prostate cancer显示文摘 | Cozzi PJ Wang J Delprado W | 2005 | Clin Exp Metastasis2005，22，： | 1 |
| 15 | Intravesical oncolytic viral therapy using attenuated replication-competent,herpes simplex viruses G207 is effective in the treatment of bladder cancer in an orthotopic syngeneic model显示文摘 | Cozzi PJ Malhotra S Mcauliffe P | 2001 | FASEB J2001，15，： | 1 |
| 16 | Role of the EpCAM (CD326) in prostate cancer metastasis and progression 显示文摘 | Ni J Cozzi PJ Duan W | 2012 | Cancer Metastasis Rev2012，31，34： | 1 |
| 17 | CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance 显示文摘 | Ni J Cozzi PJ Hao JL | 2014 | Prostate2014，74，6： | 1 |
| 18 | MUC1 is a promising therapeutic target for prostatecancer therapy显示文摘 | Li Y Cozzi PJ | 2007 | Curr Cancer Drug Targets2007，7，3： | 1 |
| 19 | Targeting uPA/uPAR in prostate cancer 显示文摘 | Li Y Cozzi PJ | 2007 | Cancer Treat Rev2007，33，6： | 1 |
| 20 | CD44 variant 6 is associated with pros- tate cancer metastasis and chemo-/radioresistance 显示文摘 | Ni J Cozzi PJ Hao JL | 2014 | Prostate2014，74，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员